Search Results - "Meyer, Reid G."

Change in Pattern of HER2 Fluorescent in Situ Hybridization (FISH) Results in Breast Cancers Submitted for FISH Testing: Experience of a Reference Laboratory Using US Food and Drug Administration Criteria and American Society of Clinical Oncology and College of American Pathologists Guidelines by Shah, Mithun Vinod, Wiktor, Anne E, Meyer, Reid G, Tenner, Kathleen S, Ballman, Karla V, Green, Stefan J, Sukov, William R, Ketterling, Rhett P, Perez, Edith A, Jenkins, Robert B

“…Purpose In 1998, the US Food and Drug Administration (FDA) approved human epidermal growth factor receptor 2 (HER2) testing guidelines to determine eligibility…”
Get full text

False-negative rates for MYC fluorescence in situ hybridization probes in B-cell neoplasms by King, Rebecca L, McPhail, Ellen D, Meyer, Reid G, Vasmatzis, George, Pearce, Kathryn, Smadbeck, James B, Ketterling, Rhett P, Smoley, Stephanie A, Greipp, Patricia T, Hoppman, Nicole L, Peterson, Jess F, Baughn, Linda B

Get full text

The Development of a Multitarget, Multicolor Fluorescence in Situ Hybridization Assay for the Detection of Urothelial Carcinoma in Urine by Sokolova, Irina A., Halling, Kevin C., Jenkins, Robert B., Burkhardt, Haleh M., Meyer, Reid G., Seelig, Steven A., King, Walter

“…The purpose of this study was to develop a multitarget, multicolor fluorescence in situ hybridization (FISH) assay for the detection of urothelial carcinoma…”
Get full text

A comparison of BTA stat, hemoglobin dipstick, telomerase and Vysis UroVysion assays for the detection of urothelial carcinoma in urine by Halling, Kevin C, King, Walter, Sokolova, Irina A, Karnes, R Jeffrey, Meyer, Reid G, Powell, Eric L, Sebo, Thomas J, Cheville, John C, Clayton, Amy C, Krajnik, Kelly L, Ebert, Thomas A, Nelson, Robert E, Burkhardt, Haleh M, Ramakumar, Sanjay, Stewart, Christopher S, Pankratz, Vernon S, Lieber, Michael M, Blute, Michael L, Zincke, Horst, Seelig, Steven A, Jenkins, Robert B, O'Kane, Dennis J

“…We determine the sensitivity and specificity of various assays for the detection of urothelial carcinoma. A total of 280 voided urine specimens from 265…”
Get more information

Warthin-like Mucoepidermoid Carcinoma of the Parotid Gland: Unusual Morphology and Diagnostic Pitfalls by Zhang, Dongwei, Liao, Xiaoyan, Tang, Yaoyun, Meyer, Reid G, VAN Dyke, Daniel L, Liu, Xiuli, Islam, Mohammed N, Lai, Jinping

“…Warthin-like mucoepidermoid carcinoma is a newly recognized rare entity and could be misdiagnosed as a benign Warthin tumor. We report such a case of a…”
Get full text

Clear-cell Variant of Mucoepidermoid Carcinoma Presenting as a Palatal Mass in a 10-Year-old Boy by Han, Sophia H, O'Toole, Thomas R, Meyer, Reid G, Geiersbach, Katherine B, Islam, Mohammed N, Cheng, Lirong, Lai, Jinping

“…The clear-cell variant of mucoepidermoid carcinoma (MEC) involving minor salivary glands is extremely rare in children. We report a case of clear-cell variant…”
Get more information

Analysis of Common Abnormalities Seen in Chronic Lymphocytic Leukemia Using Fluorescence In Situ Hybridization by Meyer, Reid G, Van Dyke, Daniel L

“…Since fluorescence in situ hybridization (FISH) was used to define a prognostic heierarchy for chronic lymphocytic leukemia (CLL) in 2000, the method has been…”
Get more information

Typical, atypical and cryptic t(15;17)(q24;q21) (PML::RARA) observed in acute promyelocytic leukemia: A retrospective review of 831 patients with concurrent chromosome and PML::RARA dual‐color dual‐fusion FISH studies by Gagnon, Marie‐France, Berg, Holly E., Meyer, Reid G., Sukov, William R., Van Dyke, Daniel L., Jenkins, Robert B., Greipp, Patricia T., Thorland, Erik C., Hoppman, Nicole L., Xu, Xinjie, Baughn, Linda B., Reichard, Kaaren K., Ketterling, Rhett P., Peterson, Jess F.

“…The diagnosis of acute promyelocytic leukemia (APL) relies on the identification of PML::RARA fusion. While the majority of APL cases harbor a typical…”
Get full text

Superior detection rate of plasma cell FISH using FACS-FISH by Gagnon, Marie-France, Midthun, Sally M, Fangel, James A, Schuh, Cynthia M, Luoma, Ivy M, Pearce, Kathryn E, Meyer, Reid G, Ailawadhi, Sikander, Arribas, Mariano J, Braggio, Esteban, Fonseca, Rafael, Rajkumar, S Vincent, Zepeda-Mendoza, Cinthya, Xu, Xinjie, Greipp, Patricia T, Timm, Michael M, Otteson, Gregory E, Shi, Min, Jevremovic, Dragan, Olteanu, Horatiu, Peterson, Jess F, Ketterling, Rhett P, Kumar, Shaji, Baughn, Linda B

“…Abstract Objectives Fluorescence in situ hybridization (FISH) for plasma cell neoplasms (PCNs) requires plasma cell (PC) identification or purification…”
Get full text

Working Up Group 4 Equivocal HER2 Samples Tested by Fluorescence in Situ Hybridization in a Reference Laboratory Setting: Past, Present, and Future by Geiersbach, Katherine B, Meyer, Reid G, Sill, Daniel R, Mounajjed, Taofic, Chen, Beiyun, Sukov, William R, Jenkins, Robert B

Get full text

KMT2A (MLL) rearrangements observed in pediatric/young adult T‐lymphoblastic leukemia/lymphoma: A 10‐year review from a single cytogenetic laboratory by Peterson, Jess F., Baughn, Linda B., Pearce, Kathryn E., Williamson, Cynthia M., Benevides Demasi, Jonna C., Olson, Renee M., Goble, Tony A., Meyer, Reid G., Greipp, Patricia T., Ketterling, Rhett P.

“…T‐lymphoblastic leukemia/lymphoma (T‐ALL/LBL) accounts for approximately 15% of pediatric and 25% of adult ALL. While the underlying frequency of KMT2A (MLL)…”
Get full text

Acute leukemias harboring KMT2A/MLLT10 fusion: a 10‐year experience from a single genomics laboratory by Peterson, Jess F., Sukov, William R., Pitel, Beth A., Smoley, Stephanie A., Pearce, Kathryn E., Meyer, Reid G., Williamson, Cynthia M., Smadbeck, James B., Vasmatzis, George, Hoppman, Nicole L., Greipp, Patricia T., Baughn, Linda B., Ketterling, Rhett P.

“…ABSTRACT The MLLT10 (formerly AF10) gene is the fourth most common KMT2A fusion partner across all acute leukemias and requires at least 3 breaks to form an…”
Get full text

HER2 Testing for Breast Cancer in the Genomics Laboratory: A Sea Change for Fluorescence In Situ Hybridization by Geiersbach, Katherine B, Sill, Daniel R, Meyer, Reid G, Yuhas, Jason A, Sukov, William R, Mounajjed, Taofic, Carter, Jodi M, Jenkins, Robert B, Chen, Beiyun

“…Context.— Guidelines for HER2 testing in breast cancer have changed over time, from the US Food and Drug Administration guideline to the American Society of…”
Get full text

Detailed Reanalysis of 500 Breast Cancers With Equivocal HER2 Immunohistochemistry and Borderline ERBB2 Fluorescence In Situ Hybridization Results: How Reflex Testing Settles the Score by Geiersbach, Katherine B, Sill, Daniel R, Del Rosario, Kristina M, Meyer, Reid G, Spears, Grant M, Yuhas, Jason A, Sukov, William R, Jenkins, Robert B, Ocal, Idris T, Mounajjed, Taofic, Chen, Beiyun

“…Objectives: We investigated the impact of our laboratory's reflex testing process for resolving ERBB2 (HER2) status on breast cancer samples that require…”
Get full text

Increased complexity of t(11;14) rearrangements in plasma cell neoplasms compared with mantle cell lymphoma by Dalland, Joanna C., Smadbeck, James B., Sharma, Neeraj, Meyer, Reid G., Pearce, Kathryn E., Greipp, Patricia T., Peterson, Jess F., Kumar, Shaji, Ketterling, Rhett P., King, Rebecca L., Baughn, Linda B.

“…Plasma cell neoplasms (PCN) and mantle cell lymphoma (MCL) can both harbor t(11;14)(q13;q32) (CCND1/IGH), usually resulting in cyclin D1 overexpression. In…”
Get full text

Detailed Reanalysis of 500 Breast Cancers With Equivocal HER2 Immunohistochemistry and Borderline ERBB2 Fluorescence In Situ Hybridization Results by Geiersbach, Katherine B, Sill, Daniel R, Del Rosario, Kristina M, Meyer, Reid G, Spears, Grant M, Yuhas, Jason A, Sukov, William R, Jenkins, Robert B, Ocal, Idris T, Mounajjed, Taofic, Chen, Beiyun

“…Abstract Objectives We investigated the impact of our laboratory’s reflex testing process for resolving ERBB2 (HER2) status on breast cancer samples that…”
Get full text

Fluorescence in‐situ hybridisation for TP63 rearrangements in T cell lymphomas: single‐site experience of 470 patients and implications for clinical testing by Peterson, Jess F, Pearce, Kathryn E, Meyer, Reid G, Greipp, Patricia T, Knudson, Ryan A, Baughn, Linda B, Ketterling, Rhett P, Feldman, Andrew L

“…Aims The aims of this study were to review our 5‐year experience with clinical FISH testing for TP63 rearrangements using both TP63 break‐apart (BAP) and…”
Get full text

High-grade B-cell lymphoma with a quadruple-hit genetic profile including concurrent MYC, BCL2, BCL6, and CCND1 gene rearrangements by Gagnon, Marie-France, Meyer, Reid G, Weaver, Eric J, Wood, Adam J, Dupuy, Dudley A, Menachery, Sudeep J, Shi, Min, Baughn, Linda B, Ketterling, Rhett P, Peterson, Jess F

“…Abstract Several reports of concurrent MYC, BCL2, BCL6, and CCND1 rearrangements in high-grade B-cell lymphoma (HGBL) have been recently described. Herein, we…”
Get full text

Integrated Analysis of HER2 Copy Number by Cytogenomic Microarray in Breast Cancers With Nonclassical In Situ Hybridization Results by Haskell, Gloria T, Liu, Yajuan J, Chen, Hui, Chen, Beiyun, Meyer, Reid G, Yuhas, Jason A, Geiersbach, Katherine B

“…Abstract Objectives To develop and test an integrated approach to human epidermal growth factor receptor 2 (HER2) copy number analysis in breast cancer using…”
Get full text

Identification of EWSR1 rearrangements in patients with immature hematopoietic neoplasms: A case series and review of literature by Gagnon, Marie-France, Smadbeck, James B., Vasmatzis, George, Olteanu, Horatiu, Wood, Adam J., Lewis, Dakota J., Sharma, Neeraj, Meyer, Reid G., Greipp, Patricia T., Xu, Xinjie, Hoppman, Nicole L., Baughn, Linda B., Ketterling, Rhett P., Chiu, April, Peterson, Jess F.

“…Rearrangement of the EWSR1 gene (22q12.2) is a well-recognized genetic lesion in bone and soft tissue tumors. However, few reports have suggested that EWSR1…”
Get full text